Literature DB >> 19914018

The utility of high b-value DWI in evaluation of ischemic stroke at 3T.

Mutlu Cihangiroglu1, Beyza Citci, Ozgur Kilickesmez, Zeynep Firat, Geysu Karlıkaya, Aziz M Uluğ, Canan A Bingol, Ilhami Kovanlikaya.   

Abstract

PURPOSE: The utility of DWI with high b-value in ischemic stroke is still unsettled. The purpose of this study is to compare high b-value (3000) and standard b-value (1000) diffusion-weighted images in patients with ischemic stroke at 3T.
MATERIALS AND METHODS: 27 patients with acute stroke who were admitted to the hospital during the first 24h after symptom onset were included in this study. All patients had a brain MRI study with stroke protocol including standard (b=1000) DWI and high b-value (b=3000) DWI sequences at 3T MR scanner. Number and localization of the lesions were assessed MR signal intensities (SI), signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR), contrast ratio (CR) and apparent diffusion coefficient (ADC) values of the lesions and normal parenchyma on DWI with b=1000 and b=3000 sequences were measured.
RESULTS: All patients with acute stroke revealed hyperintense lesions due to restricted diffusion on DWI with both b-values. However, lesions of restricted diffusion were more conspicuous in b=3000 value DWI than b=1000, and additional 4 ischemic lesions were detected on b=3000 DWI. SNR, CNR, SI and also ADC values in both stroke area and normal parenchyma were lower at b=3000 than the value at b=1000. At b=3000, CR was significantly greater than b=1000 images.
CONCLUSIONS: Although quantitative analysis shows higher SI, SNR and CNR values with standard b-value (b=1000) diffusion-weighted imaging, using higher b-value may still be beneficial in detecting additional subtle lesions in patients whose clinical findings are not correlated with standard b-value DWI in stroke.
Copyright © 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19914018     DOI: 10.1016/j.ejrad.2009.10.011

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  10 in total

1.  Preoperative grading of supratentorial nonenhancing gliomas by high b-value diffusion-weighted 3 T magnetic resonance imaging.

Authors:  Haiwei Han; Chengkun Han; Xiurong Wu; Shan Zhong; Xiongjie Zhuang; Guowei Tan; Hua Wu
Journal:  J Neurooncol       Date:  2017-04-24       Impact factor: 4.130

2.  Apparent diffusion coefficient maps obtained from high b value diffusion-weighted imaging in the preoperative evaluation of gliomas at 3T: comparison with standard b value diffusion-weighted imaging.

Authors:  Qiang Zeng; Fei Dong; Feina Shi; Chenhan Ling; Biao Jiang; Jianmin Zhang
Journal:  Eur Radiol       Date:  2017-06-21       Impact factor: 5.315

3.  Optimal b value of diffusion-weighted imaging on a 3.0T magnetic resonance scanner in Crohn's disease.

Authors:  Qi Feng; Yun-Qi Yan; Jiong Zhu; Jin-Lu Tong; Jian-Rong Xu
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

4.  Efficiency of High and Standard b Value Diffusion-Weighted Magnetic Resonance Imaging in Grading of Gliomas.

Authors:  Mansour Al-Agha; Khaled Abushab; Khetam Quffa; Samy Al-Agha; Yasser Alajerami; Mohammed Tabash
Journal:  J Oncol       Date:  2020-09-14       Impact factor: 4.375

5.  A comparison of high b-value vs standard b-value diffusion-weighted magnetic resonance imaging at 3.0 T for medulloblastomas.

Authors:  Chengkun Han; Long Zhao; Shan Zhong; Xiurong Wu; Jianfeng Guo; Xiongjie Zhuang; Haiwei Han
Journal:  Br J Radiol       Date:  2015-08-03       Impact factor: 3.039

6.  Diffusion-weighted MRI of ischemic stroke at 3T: Value of synthetic b-values.

Authors:  Thomas Sartoretti; Elisabeth Sartoretti; Michael Wyss; Manoj Mannil; Luuk van Smoorenburg; Barbara Eichenberger; Carolin Reischauer; Alex Alfieri; Christoph Binkert; Sabine Sartoretti-Schefer
Journal:  Br J Radiol       Date:  2021-02-17       Impact factor: 3.039

7.  Systematic review with network meta-analysis: Diagnostic values of ultrasonography, computed tomography, and magnetic resonance imaging in patients with ischemic stroke.

Authors:  Xiao-Hong Zhang; Hui-Min Liang
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

8.  The assessment of mild encephalopathy with a reversible splenial lesion (MERS) using high b-value DWI.

Authors:  Bimei Zhuang; Chenkun Han; Zhipeng Hua; Xiongjie Zhuang; Haiwei Han
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

9.  Integrating neuroimaging biomarkers into the multicentre, high-dose erythropoietin for asphyxia and encephalopathy (HEAL) trial: rationale, protocol and harmonisation.

Authors:  Jessica L Wisnowski; Stefan Bluml; Ashok Panigrahy; Amit M Mathur; Jeffrey Berman; Ping-Sun Keven Chen; James Dix; Trevor Flynn; Stanley Fricke; Seth D Friedman; Hayden W Head; Chang Y Ho; Beth Kline-Fath; Michael Oveson; Richard Patterson; Sumit Pruthi; Nancy Rollins; Yanerys M Ramos; John Rampton; Jerome Rusin; Dennis W Shaw; Mark Smith; Jean Tkach; Shreyas Vasanawala; Arastoo Vossough; Matthew T Whitehead; Duan Xu; Kristen Yeom; Bryan Comstock; Patrick J Heagerty; Sandra E Juul; Yvonne W Wu; Robert C McKinstry
Journal:  BMJ Open       Date:  2021-04-22       Impact factor: 2.692

10.  High b value DWI in evaluation of the hyperacute cerebral ischemia at 3T: A comparative study in an embolic canine stroke model.

Authors:  Qiguang Cheng; Xiaoquan Xu; Qingquan Zu; Shanshan Lu; Jing Yu; Xinglong Liu; Bin Wang; Haibin Shi; Gaojun Teng; Sheng Liu
Journal:  Exp Ther Med       Date:  2016-05-27       Impact factor: 2.447

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.